Affiliations

NYBA

Australia Biotech

BioMelbourne

Lab To Wall Street

Of Counsel To Firm

Seth Kaufman has two decades of experience in the real estate industry. Mr. Kaufman represents private and institutional owners, title companies, real estate brokerage houses, office tenants and private lenders in leasing, sales and financing transactions and litigation. Mr. Kaufman's business expertise also helps him resolve complex economic issues that typically arise in pre-nuptial, divorce and child support matters.

Mr. Kaufman regularly appears pro bono in Family Court proceedings and is a director of Correctional Educational Consortium, a not-for-profit organization offering educational and vocational training for at-risk populations. He has served on the Family Court Committee of the Association of the Bar of the City of New York, the Family Court and Child Custody committees of the Family Law Section of the New York State Bar Association and the Family Court and Child Welfare Committee of the New York County Lawyers' Association. Mr. Kaufman graduated from the State University of New York and the Benjamin N. Cardozo School of Law. He lives in New York City with his wife and two children.

See bio of Roger O'Sullivan >

See bio of John Balestriere >
See bio of Eric N. Cohen >

  May 28th, 2009:
Arana Therapeutics Board Changes

May 6th, 2009:
Circadian Scientific Advisory Board Chairman, Professor Kari Alitalo, Wins Prestigious Award for Biomedical Research

May 5th, 2009:
Living Cell Technologies Reports Insulin Independence in Two Patients Following Recent Implants of DIABECELL® in Diabetes Clinical Trial

November 3rd:
FDA Accepts Arana's Anti-inflammatory IND

September 4th:
Cytopia Commences Second Phase II Study in Brain Cancer

September 4th:
Pharmaxis Announces Second Pivotal Phase 3 Trial in Cystic Fibrosis Begins

August 6th:
Xenome Strengthens Board with Two New Appointments

August 6th:
Ciba Elects to Cease Industrial Product Evaluations

June 24th:
New Pharmaxis Board Appointment

April 29th:
Benitec secures further rights to HIV Therapeutic

more industry news >
 


osullivanpllc.com  

Disclaimer